retatrutide approval status 2025 fda Demand for Unapproved Weight-Loss Drug Surges on Social Media This weight-loss drug hasn't been

Semaglutide is a glucagon-like peptide 1 (GLP1) analogue which is a synthetic version of a gut-brain axis hormone initially called incretin, because it increased insulin secretion

In a statement, the Danish company said the move would help to address "access barriers" to the medicines and "make it easier and more affordable for people in the US to get authentic, FDA-approved Wegovy and Ozempic in the way that best fits their lives." There's little doubt that one of the reasons for the move will be to try to keep pace with arch-rival Eli Lilly in the market for incretin-based therapies for obesity and T2D, particularly the strong growth of Lilly's dual GIP/GLP-1 agonist tirzepatide, whose growth rate is outstripping Novo Nordisk's products

Retatrutide itself is a synthetic peptide studied within metabolic and endocrine research

Photo Credit: Baldwin Publishing Staff Photographer 45 mins This salad is packed with lean protein and fresh crunch, making it a great option when you need maximum nutrition in the middle of the day

From restaurant meals to home-cooked recipes, there is a good chance that someone has already entered the nutritional data